Stocks News

LAST PRICE
315.9300
TODAY'S CHANGE (%)
Trending Up2.6000 (0.8298%)

Bid / Lots
315.9100/ 3
Ask / Lots
316.1400/ 3
Open / Previous Close
312.9700 / 313.3300
Day Range
Low 310.1800
High 316.9550
52 Week Range
Low 221.1950
High 344.7700
Volume
186,510
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Jun 6, 2024
- DJ Icon Initiated at Buy by Goldman Sachs, from 9:09AM ET on Thursday Jun 06, 2024 by Dow Jones
  9:09AM ET on Thursday Jun 06, 2024 by Dow Jones
  Companies Mentioned: ICLR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ICLR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  June 06, 2024 09:09 ET (13:09 GMT)
Jun 4, 2024
- ICON plc to Present at the Jefferies Global Healthcare Conference, from 6:00AM ET on Tuesday Jun 04, 2024 by Business Wire
  6:00AM ET on Tuesday Jun 04, 2024 by Business Wire
  Companies Mentioned: ICLR
  ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET.
- ICON plc to Present at the Jefferies Global Healthcare Conference, from 6:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
  6:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
  Companies Mentioned: ICLR
  DUBLIN--(BUSINESS WIRE)--June 04, 2024--
  ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET.
May 31, 2024
- DJ Icon Is Maintained at Buy by TD Cowen, from 1:39PM ET on Friday May 31, 2024 by Dow Jones
  1:39PM ET on Friday May 31, 2024 by Dow Jones
  Companies Mentioned: ICLR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ICLR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 31, 2024 13:39 ET (17:39 GMT)
- Baird Adjusts Price Target on ICON to $367 From $363, Maintains Outperform Rating, from 8:46AM ET on Friday May 31, 2024 by MT Newswires
  8:46AM ET on Friday May 31, 2024 by MT Newswires
  Companies Mentioned: ICLR
  08:46 AM EDT, 05/31/2024 (MT Newswires) -- ICON (ICLR) has an average buy rating and a price target range of $268 to $390, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major banks and ...

Today
- Top Midday Stories: Nvidia Gets SCOTUS Review of Crypto Sales Lawsuit; Apple Supplier Develops Material for Solid-State Batteries; OpenAI Reportedly Launches Medical AI Tool; Walt Disney's 'Inside Out 2' Sets Biggest Opening of 2024; IQVentures to Acquire Aaron's, from 1 hour ago by MT Newswires
  1 hour ago by MT Newswires
  Companies Mentioned: MSFT, NVDA, AAN, AAPL, BNTX, DIS
- Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading, from 1 hour ago by MT Newswires
  1 hour ago by MT Newswires
  Companies Mentioned: ING, LYG, SNY, TRIB, VRNA, NCNA, AKTX, MREO, BNTX, SLN, EVAX, DBVT, CRH, ASND, CLLS, SAN
- Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 2 hours ago by Accesswire
  2 hours ago by Accesswire
  Companies Mentioned: MRNA
- BioNTech Says US FDA Placed Partial Clinical Hold on Cancer Drug Trial, from 3 hours ago by MT Newswires
  3 hours ago by MT Newswires
  Companies Mentioned: BNTX
- Grifols' Biotest Gets FDA Approval for Yimmugo, from 4 hours ago by MT Newswires
  4 hours ago by MT Newswires
  Companies Mentioned: GRFS
- Grifols' Biotest receives FDA approval for innovative Yimmugo(R) immunoglobulin to treat primary immunodeficiencies, from 8 hours ago by GlobeNewswire
  8 hours ago by GlobeNewswire
  Companies Mentioned: GIKLY
Yesterday
- Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 11:00AM ET on Sunday Jun 16, 2024 by Accesswire
  11:00AM ET on Sunday Jun 16, 2024 by Accesswire
  Companies Mentioned: MRNA
Jun 15, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA, from 12:45PM ET on Saturday Jun 15, 2024 by PR Newswire
  12:45PM ET on Saturday Jun 15, 2024 by PR Newswire
  Companies Mentioned: MRNA
Jun 14, 2024
- Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 11:01AM ET on Friday Jun 14, 2024 by Accesswire
  11:01AM ET on Friday Jun 14, 2024 by Accesswire
  Companies Mentioned: MRNA
Jun 13, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA, from 3:38PM ET on Thursday Jun 13, 2024 by GlobeNewswire
  3:38PM ET on Thursday Jun 13, 2024 by GlobeNewswire
  Companies Mentioned: MRNA

ICON PLC
NASDAQ:ICLRUnited States

Search Criteria

Jun 6, 2024

DJ Icon Initiated at Buy by Goldman Sachs, from 9:09AM ET on Thursday Jun 06, 2024 by Dow Jones

Jun 4, 2024

ICON plc to Present at the Jefferies Global Healthcare Conference, from 6:00AM ET on Tuesday Jun 04, 2024 by Business Wire

ICON plc to Present at the Jefferies Global Healthcare Conference, from 6:00AM ET on Tuesday Jun 04, 2024 by Dow Jones

May 31, 2024

DJ Icon Is Maintained at Buy by TD Cowen, from 1:39PM ET on Friday May 31, 2024 by Dow Jones

Baird Adjusts Price Target on ICON to $367 From $363, Maintains Outperform Rating, from 8:46AM ET on Friday May 31, 2024 by MT Newswires

Peers Headlines

Today

Top Midday Stories: Nvidia Gets SCOTUS Review of Crypto Sales Lawsuit; Apple Supplier Develops Material for Solid-State Batteries; OpenAI Reportedly Launches Medical AI Tool; Walt Disney's 'Inside Out 2' Sets Biggest Opening of 2024; IQVentures to Acquire Aaron's, from 1 hour ago by MT Newswires

Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading, from 1 hour ago by MT Newswires

Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 2 hours ago by Accesswire

BioNTech Says US FDA Placed Partial Clinical Hold on Cancer Drug Trial, from 3 hours ago by MT Newswires

Grifols' Biotest Gets FDA Approval for Yimmugo, from 4 hours ago by MT Newswires

Grifols' Biotest receives FDA approval for innovative Yimmugo(R) immunoglobulin to treat primary immunodeficiencies, from 8 hours ago by GlobeNewswire

Yesterday

Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 11:00AM ET on Sunday Jun 16, 2024 by Accesswire

Jun 15, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA, from 12:45PM ET on Saturday Jun 15, 2024 by PR Newswire

Jun 14, 2024

Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 11:01AM ET on Friday Jun 14, 2024 by Accesswire

Jun 13, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA, from 3:38PM ET on Thursday Jun 13, 2024 by GlobeNewswire